CBIO
:NASDAQ

Add to watchlist
$0.6400
Last updated:01/21/2022
CBIO: NASDAQ
$0.6400
Catalyst Biosciences Inc

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company engineer proteases to develop improved or novel molecules to treat diseases that result from dysregulation of the complement and coagulation cascades. Its protease engineering platform has generated two late-st…

Dividend yield
-
P/E ratio
-
vs. 0.00x forward
Payout ratio
-
Yearly
CASH payout ratio
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months
Become our supporter to unlock all data!
CBIO dividends
Create free account to unlock
Company results
Qtr
Ann
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Company value
Market capitalization
Nano (24.64M)